Updates matching "National"

Our thoughts and well wishes are with Sen. Amy Klobuchar, D-Minn., as she shares her personal journey with early-stage breast cancer. Sen. Klobuchar’s recent statements on the importance of routine screenings and follow-up are reminders that finding cancer early can give the best chance for successful treatment.

More than a dozen patient advocacy organizations are commending the House Ways and Means Committee as it begins considering details of legislation to create the country’s first ever national paid family and medical leave program as part of the budget reconciliation package.

The American Cancer Society Cancer Action Network (ACS CAN) is calling on the Departments of Health and Human Services, Labor and Treasury to put cancer patients and survivors first when implementing rules around surprise medical bills.

The U.S. Food and Drug Administration issued marketing denial orders (MDOs) to 31 companies who sought to sell 300,000 flavored electronic cigarettes. The decision requires these manufacturers to remove those identified products already on the market.

The U.S. Food and Drug Administration issued its first denials of flavored electronic cigarettes after the agency determined the manufacturer’s products pose a greater risk to public health than any potential benefit.

Washington, D.C.— The DIVERSE Trials Act, introduced in both the House and Senate would increase diversity in clinical trials and make it easier for all cancer patients to participate in clinical trials. The bipartisan bicameral legislation, sponsored by Sens. Robert Menendez (D-N.J.) and Tim Scott (R-S.C.), and Reps. Raul

Today the president called on Congress to bring down patient prescription drug costs, an issue of critical importance to cancer patients. Among the provisions the president outlined was establishing an annual cap on Medicare enrollees’ out-of-pocket expenses.

Late last week the administration rescinded a proposed rule that would have tied the price of select Medicare Part B drugs to that of foreign countries. Of the 50 drugs selected for participation under the Most Favored Nation rule, 35 would have been cancer drugs.

More than two dozen patient groups and health care partners are joining forces to call for a comprehensive paid family and medical leave program, including caregiving leave.